Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-570-0 | CAS number: 108-30-5
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981-03-11 to 1981-04-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted 12 May 1981
- Deviations:
- no
- Principles of method if other than guideline:
- standard protocol for determination of acute median lethal oral dose.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Succinic anhydride
- EC Number:
- 203-570-0
- EC Name:
- Succinic anhydride
- Cas Number:
- 108-30-5
- Molecular formula:
- C4H4O3
- IUPAC Name:
- succinic anhydride
Constituent 1
- Specific details on test material used for the study:
- Succinic anhydride appeared as white solid flakes
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- After an acclimation period of at least 7 days, animals were assigned to groups of two males and two females at five dose levels for the preliminary study and five males and five females at six dose levels for the principal study. Animals were individually housed in wire mesh bottom cages in environment controlled rooms.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- Animals were fasted overnight prior to receiving a single oral dose of the test article at five dosing levels. The test article was administered at a constant concentration and the volume of dosing solution did not exceed 5 mL per animal, where possible.
- Doses:
- Preliminary study: 50, 139, 387, 1078 and 3000 mg/kg; Principal study: 1214, 1500, 1854, 2291, 2832, and 3500 mg/kg
- No. of animals per sex per dose:
- Preliminary study: 2 males and 2 females per dose; Principal study: 5 males and 5 females per dose
- Control animals:
- no
- Details on study design:
- All animals on the main study were observed for at least 14 days or until all signs of reversible toxicity subsided, whichever occurred later. Animals were observed three times a day on the day of dosing and twice daily for the remainder of the study. All gross or visible toxic or pharmacological effects were recorded. Body weights were recorded initially and on days 8 and 15 or at death. All animals that died and all animals sacrificed at termination were subject to gross necropsy.
- Statistics:
- No details but graphical representations indicate probit analysis used to determine the median lethal dose
Results and discussion
- Preliminary study:
- The preliminary dose range -finding study gave mortality results at dose levels of 50 (0/4); 139 (0/4); 387 (0/4); 1078 (0/4) or 3000 (4/4) mg/kg bw
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 157.2 mg/kg bw
- 95% CL:
- 1 722.2 - 2 758.6
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 510.5 mg/kg bw
- 95% CL:
- 1 086.9 - 1 816.7
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 794.9 mg/kg bw
- 95% CL:
- 1 505 - 2 071.5
- Mortality:
- For male rats, cumulative mortality at dose levels of 1214, 1500, 1854, 2291, 2832, and 3500 mg/kg was 0/5, 1/5, 2/5, 3/5, 3/5 and 5/5, respectively. For female rats, cumulative mortality at the same dose levels was 1/5, 3/5, 3/5, 5/5, 5/5 and 5/5, respectively. (see Table 1 in section "Any other information on results incl. tables" for details on mortality data)
- Clinical signs:
- In males at dose levels of 1500 mg/kg and higher, decreased activity and death was seen. Soft stools were reported for males dosed at 2291 mg/kg and ataxia was observed for males at the two highest dose levels. In females, decreased activity and death was observed at all dose levels. Soft stools were observed in females dosed at 1214 mg/kg and ataxia was observed at doses of 1500 mg/kg and higher.
- Body weight:
- For details on body weight see Table 2 in section "Any other information on results incl. tables" .
- Gross pathology:
- Black pylorus in stomach and intestines containing a blood-like substance were seen in males at doses of 2291 mg/kg and above. At the highest dose, green areas on the lungs were seen in males at necropsy. In females, black stomach pyloric and intestines containing a blood-like substance were seen at doses of 1854 mg/kg and higher. At necropsy, green areas on the lungs were seen in females dosed at 2291 and 3500 mg/kg.
- Other findings:
- No data
Any other information on results incl. tables
Table 1. Mortality data
Time of Death |
||||||
| Dose level (mg/kg) | Day 1 | Day 2 | Day 3 | Day 8 | Day 15 | Cumulative mortality |
| Males | ||||||
1214 |
0 | 0 | 0 | 0 | 0 | 0/5 |
| 1500 | 0 | 1 | 0 | 0 | 0 | 1/5 |
| 1854 | 1 | 0 | 1 | 0 | 0 | 2/5 |
| 2291 | 0 | 3 | 0 | 0 | 0 | 3/5 |
| 2832 | 3 | 0 | 0 | 0 | 0 | 3/5 |
| 3500 | 5 | -- | -- | -- | -- | 5/5 |
| Females | ||||||
| 1214 | 1 | 0 | 0 | 0 | 0 | 1/5 |
| 1500 | 0 | 3 | 0 | 0 | 0 | 3/5 |
| 1854 | 1 | 2 | 0 | 0 | 0 | 3/5 |
| 2291 | 3 | 2 | -- | -- | -- | 5/5 |
| 2832 | 5 | -- | -- | -- | -- | 5/5 |
| 3500 | 5 | -- | -- | -- | -- | 5/5 |
Table 2. Summary of body weights
Body weights (mean + SD) |
||||
| Dose level (mg/kg) | Initial* | 8 days | 15 days | at death |
| Males | ||||
| 1214# | 188.8 + 14.9 | 254.4 + 11.4 | 281.6 + 12.5 | -- |
| 1500 | 319.8 + 23.3 | 346.3 + 40.4 | 365.3 + 38.5 | 294.0 |
| 1854 | 322.8 + 8.3 | 348.0 + 19.1 | 372.7 + 16.3 | 307.0 + 35.4 |
| 2291 | 324.8 + 24.5 | 359.5 + 12.0 | 386.0 + 5.7 | 308.7 + 12.1 |
| 2832 | 318.0 + 16.1 | 364.5 + 12.0 | 385.5 + 13.4 | 312.7 + 19.4 |
| 3500 | 306.0 + 20.4 | -- | -- | 306.0 + 20.4 |
| Females | ||||
| 1214# | 191.2 + 6.4 | 226.0 + 12.3 | 227.0 + 12.3 | 188.0 |
| 1500 | 222.0 + 15.7 | 239.0 + 7.1 | 249.0 + 9.9 | 208.7 + 17.2 |
| 1854 | 214.4 + 9.3 | 247.0 + 15.6 | 255.0 + 24.0 | 210.0 + 11.1 |
| 2291 | 230.4 + 28.2 | -- | -- | 227.2 + 25.2 |
| 2832 | 225.6 + 8.6 | -- | -- | 225.6 + 8.6 |
| 3500 | 231.2 + 19.8 | -- | -- | 231.2 + 19.8 |
| *Fasted body weight # Dosed on a different day | ||||
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The results of this study indicate that succinic anhydride is of low acute oral toxicity when tested according to OECD test guideline 401. The combined LD50 for males and females is 1794.9 mg/kg bw. This result would indicate classification for acute toxicity Cat.4, H302 (Harmful if swallowed) according to the CLP criteria as set out in Regulation (EC) 1272/2008 may be appropriate.
- Executive summary:
In an acute oral toxicity study performed according to OECD TG 401, groups of 5 fasted Sprague-Dawley rats/sex were given a single oral dose of succinic anhydride by gavage at doses of 1214, 1500, 1854, 2291, 2832 and 3500 mg/kg bw and observed for at least 14 days.
For male rats, cumulative mortality at dose levels of 1214, 1500, 1854, 2291, 2832, and 3500 mg/kg was 0/5, 1/5, 2/5, 3/5, 3/5 and 5/5, respectively. For female rats, cumulative mortality at the same dose levels was 1/5, 3/5, 3/5, 5/5, 5/5 and 5/5, respectively.
The oral LD50 value was 2157.2 mg/kg bw for males and 1510.5 mg/kg bw for females. The combined oral LD50 was 1794.9 mg/kg bw.
Clinical signs included decreased activity in males at dose levels of 1500 mg/kg and higher. Soft stools were reported for males dosed at 2291 mg/kg and ataxia was observed for males at the two highest dose levels.
In females, decreased activity was observed at all dose levels. Soft stools were observed in females dosed at 1214 mg/kg and ataxia was observed at doses of 1500 mg/kg and higher.
Black pylorus in stomach and intestines containing a blood-like substance were seen in males at doses of 2291 mg/kg and above and in females at doses of 1854 mg/kg and higher.
At the highest dose in males, green areas on the lungs were seen at necropsy. In females, these effects were observed at doses levels of 2291 and 3500 mg/kg.
Succinic anhydride is of low toxicity based on the combined LD50 of 1794.9 mg/kg bw. Classification to Category 4 for acute oral toxicity is warranted according to the CLP criteria as set out in Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
